Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 1 country.
Nisha SinghDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Agustin RolandelliDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Anya J O'NealDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
L Rainer ButlerDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.
Sourabh SamaddarDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0003-0746-3924
Hanna J Laukaitis-YouseyDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0002-2267-4634
Matthew ButnaruDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Stephanie E MohrDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Norbert PerrimonDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
Joao H F PedraDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA.ORCID 0000-0001-8740-2667
University of Maryland, Baltimore · USHoward Hughes Medical Institute · USHarvard University · US
Funding
Tick Resources CoreP01AI138949 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI UTPAL PAL · 2018 to 2026
$13.5M
Ubiquitylation and Rickettsial Colonization of a Tick VectorR01AI116523 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PEDRA, JOAO · 2016 to 2025
$6.2M
Tick Saliva and Pathogen TransmissionR01AI134696 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Joao Pedra · 2018 to 2026
$5.1M
Systems-Level Research in Microbial PathogenesisT32AI162579 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NICHOLAS H CARBONETTI, Julie Dunning Hotopp · 2022 to 2026
$1.7M
Establishing CRISPR cell screening for the deer tick Ixodes scapularis, a vector of Lyme and other diseasesR21AI168592 · NIAID · HARVARD MEDICAL SCHOOL · PI MOHR, STEPHANIE E, PEDRA, JOAO · 2022 to 2023
$469k
Regulation of Skin Immunity by a Tick BiteR21AI165520 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PEDRA, JOAO · 2022 to 2023
$425k
Characterization of a Lipid Receptor in Tick Humoral ImmunityF31AI152215 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI O’NEAL, ANYA JOSEPHINE · 2020 to 2021
$81k
Rab27 in tick extracellular vesicle biogenesisF31AI167471 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BUTLER, LILLIAN RAINER · 2022 to 2023
Although genetic manipulation is one of the hallmarks of model organisms, its applicability to non-model species has remained difficult due to our limited understanding of their fundamental biology. For instance, manipulation of a cell line originated from the black-legged tick
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic manipulation of an · full record | OpenQuestion